Cargando…

Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer

Prostate specific membrane antigen (PSMA) over-expression is a hallmark of prostate adenocarcinoma and many PSMA targeting positron emission tomography (PET) radiopharmaceuticals have been developed over the last decade. The role of 68Ga-PSMA-11 PET-computed tomography (CT) is well established in st...

Descripción completa

Detalles Bibliográficos
Autor principal: Singh, Harmandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905282/
https://www.ncbi.nlm.nih.gov/pubmed/33642750
http://dx.doi.org/10.4103/ijnm.IJNM_175_20
_version_ 1783655079129120768
author Singh, Harmandeep
author_facet Singh, Harmandeep
author_sort Singh, Harmandeep
collection PubMed
description Prostate specific membrane antigen (PSMA) over-expression is a hallmark of prostate adenocarcinoma and many PSMA targeting positron emission tomography (PET) radiopharmaceuticals have been developed over the last decade. The role of 68Ga-PSMA-11 PET-computed tomography (CT) is well established in staging and biochemical recurrence of PCa, with growing interest and evidence regarding its utility in suspected prostate cancer.
format Online
Article
Text
id pubmed-7905282
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-79052822021-02-26 Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer Singh, Harmandeep Indian J Nucl Med Commentary Prostate specific membrane antigen (PSMA) over-expression is a hallmark of prostate adenocarcinoma and many PSMA targeting positron emission tomography (PET) radiopharmaceuticals have been developed over the last decade. The role of 68Ga-PSMA-11 PET-computed tomography (CT) is well established in staging and biochemical recurrence of PCa, with growing interest and evidence regarding its utility in suspected prostate cancer. Wolters Kluwer - Medknow 2020 2020-10-21 /pmc/articles/PMC7905282/ /pubmed/33642750 http://dx.doi.org/10.4103/ijnm.IJNM_175_20 Text en Copyright: © 2020 Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Commentary
Singh, Harmandeep
Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
title Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
title_full Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
title_fullStr Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
title_full_unstemmed Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
title_short Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
title_sort making the case for prostate-specific membrane antigen-targeted positron emission tomography/computed tomography in suspected prostate cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905282/
https://www.ncbi.nlm.nih.gov/pubmed/33642750
http://dx.doi.org/10.4103/ijnm.IJNM_175_20
work_keys_str_mv AT singhharmandeep makingthecaseforprostatespecificmembraneantigentargetedpositronemissiontomographycomputedtomographyinsuspectedprostatecancer